Characterization of the hog cholera virus 5' terminus. 1995

K Katayama, and C Kurihara, and S Fukushi, and F B Hoshino, and K Ishikawa, and H Nagai, and T Ando, and A Oya
Basic Research Division, BioMedical Laboratories, Saitama, Japan.

Hog cholera virus (HoCV) 5' terminus of the ALD and GPE(-) strains were analyzed by using rapid amplification of cDNA end method (5'RACE). An additional nine nucleotides were found at the 5' termini of genomic RNA in the ALD and GPE(-) strains of HoCV. These nine nucleotides were also conserved in BVDV and were suggested to form a hairpin structure at the 5' terminus by computer-assisted analysis. It seems possible that the secondary structure and/or the 5' terminus sequence has a significant role in the HoCV virus genome.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009690 Nucleic Acid Conformation The spatial arrangement of the atoms of a nucleic acid or polynucleotide that results in its characteristic 3-dimensional shape. DNA Conformation,RNA Conformation,Conformation, DNA,Conformation, Nucleic Acid,Conformation, RNA,Conformations, DNA,Conformations, Nucleic Acid,Conformations, RNA,DNA Conformations,Nucleic Acid Conformations,RNA Conformations
D006692 Classical Swine Fever Virus A species of the PESTIVIRUS genus causing exceedingly contagious and fatal hemorrhagic disease of swine. Hog Cholera Virus,Swine Fever Virus,Swine Fever Virus, Classical,Cholera Virus, Hog
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA
D012367 RNA, Viral Ribonucleic acid that makes up the genetic material of viruses. Viral RNA
D012689 Sequence Homology, Nucleic Acid The sequential correspondence of nucleotides in one nucleic acid molecule with those of another nucleic acid molecule. Sequence homology is an indication of the genetic relatedness of different organisms and gene function. Base Sequence Homology,Homologous Sequences, Nucleic Acid,Homologs, Nucleic Acid Sequence,Homology, Base Sequence,Homology, Nucleic Acid Sequence,Nucleic Acid Sequence Homologs,Nucleic Acid Sequence Homology,Sequence Homology, Base,Base Sequence Homologies,Homologies, Base Sequence,Sequence Homologies, Base
D013045 Species Specificity The restriction of a characteristic behavior, anatomical structure or physical system, such as immune response; metabolic response, or gene or gene variant to the members of one species. It refers to that property which differentiates one species from another but it is also used for phylogenetic levels higher or lower than the species. Species Specificities,Specificities, Species,Specificity, Species
D014613 Vaccines, Attenuated Live vaccines prepared from microorganisms which have undergone physical adaptation (e.g., by radiation or temperature conditioning) or serial passage in laboratory animal hosts or infected tissue/cell cultures, in order to produce avirulent mutant strains capable of inducing protective immunity. Attenuated Vaccine,Vaccines, Live, Attenuated,Attenuated Vaccines,Vaccine, Attenuated
D014765 Viral Vaccines Suspensions of attenuated or killed viruses administered for the prevention or treatment of infectious viral disease. Viral Vaccine,Vaccine, Viral,Vaccines, Viral

Related Publications

K Katayama, and C Kurihara, and S Fukushi, and F B Hoshino, and K Ishikawa, and H Nagai, and T Ando, and A Oya
January 1991, Archives of virology. Supplementum,
K Katayama, and C Kurihara, and S Fukushi, and F B Hoshino, and K Ishikawa, and H Nagai, and T Ando, and A Oya
November 1989, Berliner und Munchener tierarztliche Wochenschrift,
K Katayama, and C Kurihara, and S Fukushi, and F B Hoshino, and K Ishikawa, and H Nagai, and T Ando, and A Oya
July 1992, Comparative immunology, microbiology and infectious diseases,
K Katayama, and C Kurihara, and S Fukushi, and F B Hoshino, and K Ishikawa, and H Nagai, and T Ando, and A Oya
January 1967, Proceedings, annual meeting of the United States Animal Health Association,
K Katayama, and C Kurihara, and S Fukushi, and F B Hoshino, and K Ishikawa, and H Nagai, and T Ando, and A Oya
January 1885, Public health papers and reports,
K Katayama, and C Kurihara, and S Fukushi, and F B Hoshino, and K Ishikawa, and H Nagai, and T Ando, and A Oya
August 1950, Medycyna weterynaryjna,
K Katayama, and C Kurihara, and S Fukushi, and F B Hoshino, and K Ishikawa, and H Nagai, and T Ando, and A Oya
September 1968, American journal of veterinary research,
K Katayama, and C Kurihara, and S Fukushi, and F B Hoshino, and K Ishikawa, and H Nagai, and T Ando, and A Oya
October 1941, The Journal of experimental medicine,
K Katayama, and C Kurihara, and S Fukushi, and F B Hoshino, and K Ishikawa, and H Nagai, and T Ando, and A Oya
May 1975, American journal of veterinary research,
K Katayama, and C Kurihara, and S Fukushi, and F B Hoshino, and K Ishikawa, and H Nagai, and T Ando, and A Oya
December 1966, Journal of bacteriology,
Copied contents to your clipboard!